Molecule Details
| InChIKey | GKDRMWXFWHEQQT-UHFFFAOYSA-N |
|---|---|
| Compound Name | Fostamatinib |
| Canonical SMILES | COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 7 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.83 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12010 |
|---|---|
| Drug Name | Fostamatinib |
| CAS Number | 901119-35-5 |
| Groups | approved investigational |
| ATC Codes | B02BX09 |
| Description | Fostamatinib has been investigated for the treatment and basic science of Rheumatoid Arthritis and Immune Thrombocytopenic Purpura (ITP). It was approved on April 17, 2018, under the trade name Tavalisse for use in ITP [L2644, L52150]. Fostamatinib has also been granted orphan drug status by the FDA... |
Categories: Amines BCRP/ABCG2 Inhibitors Blood and Blood Forming Organs Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Experimental Unapproved Treatments for COVID-19 Hemostatics Kinase Inhibitor Oxazines Phosphodiesterase 5 Inhibitors Pyridines Tyrosine Kinase Inhibitors UGT1A1 Inhibitors UGT1A9 Substrates Vasodilating Agents
Cross-references: BindingDB: 50431381 CHEMBL2103830 ChemSpider: 9846198 Drugs Product Database (DPD): 23528 PDB: 2RC PubChem:11671467 PubChem:347828328 RxCUI: 2044896 Wikipedia: Fostamatinib ZINC: ZINC000043131420
Target Activities (7)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P43405 | SYK | Homo sapiens | Human | PF07714 PF00017 | 7.5 | IC50 | ChEMBL;BindingDB |
| Q8TD19 | NEK9 | Homo sapiens | Human | PF00069 PF25390 | 7.4 | Kd | ChEMBL |
| Q9UNQ0 | ABCG2 | Homo sapiens | Human | PF01061 PF19055 PF00005 | 7.3 | IC50 | ChEMBL;BindingDB |
| Q13470 | TNK1 | Homo sapiens | Human | PF07714 PF22931 | 6.8 | Kd | ChEMBL |
| O14965 | AURKA | Homo sapiens | Human | PF00069 | 6.5 | Kd | ChEMBL |
| O00444 | PLK4 | Homo sapiens | Human | PF00069 PF18190 PF18409 | 6.2 | Kd | ChEMBL |
| P36888 | FLT3 | Homo sapiens | Human | PF00047 PF07714 | 6.1 | Kd | ChEMBL |
DrugBank Target Actions (304)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P08684 | CYP3A4 | Cytochrome P450 3A4 | inhibitor | enzymes |
| O60656 | O60656 | UDP-glucuronosyltransferase 1A9 | substrate | enzymes |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | substrate | enzymes |
| P0DMS8 | ADORA3 | Adenosine receptor A3 | antagonist | targets |
| O00238 | BMPR1B | Bone morphogenetic protein receptor type-1B | inhibitor | targets |
| O00329 | PIK3CD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | inhibitor | targets |
| O00444 | PLK4 | Serine/threonine-protein kinase PLK4 | inhibitor | targets |
| O00519 | FAAH | Fatty-acid amide hydrolase 1 | inhibitor | targets |
| O00750 | PIK3C2B | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | inhibitor | targets |
| O14578 | CIT | Citron Rho-interacting kinase | inhibitor | targets |
| O14730 | RIOK3 | Serine/threonine-protein kinase RIO3 | inhibitor | targets |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | inhibitor | targets |
| O14920 | IKBKB | Inhibitor of nuclear factor kappa-B kinase subunit beta | inhibitor | targets |
| O14936 | CASK | Peripheral plasma membrane protein CASK | inhibitor | targets |
| O14965 | AURKA | Aurora kinase A | inhibitor | targets |
| O14976 | GAK | Cyclin-G-associated kinase | inhibitor | targets |
| O15075 | DCLK1 | Serine/threonine-protein kinase DCLK1 | inhibitor | targets |
| O15146 | MUSK | Muscle, skeletal receptor tyrosine-protein kinase | inhibitor | targets |
| O15197 | EPHB6 | Ephrin type-B receptor 6 | inhibitor | targets |
| O15264 | MAPK13 | Mitogen-activated protein kinase 13 | inhibitor | targets |
| O15530 | PDPK1 | 3-phosphoinositide-dependent protein kinase 1 | inhibitor | targets |
| O43283 | MAP3K13 | Mitogen-activated protein kinase kinase kinase 13 | inhibitor | targets |
| O43293 | DAPK3 | Death-associated protein kinase 3 | inhibitor | targets |
| O43353 | RIPK2 | Receptor-interacting serine/threonine-protein kinase 2 | inhibitor | targets |
| O60285 | NUAK1 | NUAK family SNF1-like kinase 1 | inhibitor | targets |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | inhibitor | targets |
| O75116 | ROCK2 | Rho-associated protein kinase 2 | inhibitor | targets |
| O75385 | ULK1 | Serine/threonine-protein kinase ULK1 | inhibitor | targets |
| O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | inhibitor | targets |
| O75716 | STK16 | Serine/threonine-protein kinase 16 | inhibitor | targets |
| O75747 | PIK3C2G | Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma | inhibitor | targets |
| O75914 | PAK3 | Serine/threonine-protein kinase PAK 3 | inhibitor | targets |
| O76074 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | inhibitor | targets |
| O94768 | STK17B | Serine/threonine-protein kinase 17B | inhibitor | targets |
| O94804 | STK10 | Serine/threonine-protein kinase 10 | inhibitor | targets |
| O95382 | MAP3K6 | Mitogen-activated protein kinase kinase kinase 6 | inhibitor | targets |
| O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | inhibitor | targets |
| O95819 | MAP4K4 | Mitogen-activated protein kinase kinase kinase kinase 4 | inhibitor | targets |
| O95835 | LATS1 | Serine/threonine-protein kinase LATS1 | inhibitor | targets |
| O96013 | PAK4 | Serine/threonine-protein kinase PAK 4 | inhibitor | targets |
| O96017 | CHEK2 | Serine/threonine-protein kinase Chk2 | inhibitor | targets |
| P00519 | ABL1 | Tyrosine-protein kinase ABL1 | inhibitor | targets |
| P00533 | EGFR | Epidermal growth factor receptor | inhibitor | targets |
| P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | inhibitor | targets |
| P04626 | ERBB2 | Receptor tyrosine-protein kinase erbB-2 | inhibitor | targets |
| P04629 | NTRK1 | High affinity nerve growth factor receptor | inhibitor | targets |
| P05129 | PRKCG | Protein kinase C gamma type | inhibitor | targets |
| P06213 | INSR | Insulin receptor | inhibitor | targets |
| P06239 | LCK | Tyrosine-protein kinase Lck | inhibitor | targets |
| P06241 | FYN | Tyrosine-protein kinase Fyn | inhibitor | targets |
| P06493 | CDK1 | Cyclin-dependent kinase 1 | inhibitor | targets |
| P07332 | FES | Tyrosine-protein kinase Fes/Fps | inhibitor | targets |
| P07333 | CSF1R | Macrophage colony-stimulating factor 1 receptor | inhibitor | targets |
| P07498 | P07498 | Kappa-casein | inhibitor | targets |
| P07711 | CTSL | Procathepsin L | inhibitor | targets |
| P07947 | YES1 | Tyrosine-protein kinase Yes | inhibitor | targets |
| P07948 | LYN | Tyrosine-protein kinase Lyn | inhibitor | targets |
| P07949 | RET | Proto-oncogene tyrosine-protein kinase receptor Ret | inhibitor | targets |
| P08581 | MET | Hepatocyte growth factor receptor | inhibitor | targets |
| P08631 | HCK | Tyrosine-protein kinase HCK | inhibitor | targets |
| P08922 | ROS1 | Proto-oncogene tyrosine-protein kinase ROS | inhibitor | targets |
| P09619 | PDGFRB | Platelet-derived growth factor receptor beta | inhibitor | targets |
| P09769 | FGR | Tyrosine-protein kinase Fgr | inhibitor | targets |
| P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | inhibitor | targets |
| P0C264 | SBK3 | Uncharacterized serine/threonine-protein kinase SBK3 | inhibitor | targets |
| P10721 | KIT | Mast/stem cell growth factor receptor Kit | inhibitor | targets |
| P11309 | PIM1 | Serine/threonine-protein kinase pim-1 | inhibitor | targets |
| P11362 | FGFR1 | Fibroblast growth factor receptor 1 | inhibitor | targets |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | inhibitor | targets |
| P12931 | SRC | Proto-oncogene tyrosine-protein kinase Src | inhibitor | targets |
| P14616 | INSRR | Insulin receptor-related protein | inhibitor | targets |
| P15056 | BRAF | Serine/threonine-protein kinase B-raf | inhibitor | targets |
| P16234 | PDGFRA | Platelet-derived growth factor receptor alpha | inhibitor | targets |
| P16591 | FER | Tyrosine-protein kinase Fer | inhibitor | targets |
| P17612 | PRKACA | cAMP-dependent protein kinase catalytic subunit alpha | inhibitor | targets |
| P17948 | FLT1 | Vascular endothelial growth factor receptor 1 | inhibitor | targets |
| P19525 | EIF2AK2 | Interferon-induced, double-stranded RNA-activated protein kinase | inhibitor | targets |
| P19784 | CSNK2A2 | Casein kinase II subunit alpha' | inhibitor | targets |
| P21709 | EPHA1 | Ephrin type-A receptor 1 | inhibitor | targets |
| P21802 | FGFR2 | Fibroblast growth factor receptor 2 | inhibitor | targets |
| P22309 | UGT1A1 | UDP-glucuronosyltransferase 1A1 | inhibitor | targets |
| P22607 | FGFR3 | Fibroblast growth factor receptor 3 | inhibitor | targets |
| P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | inhibitor | targets |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | inhibitor | targets |
| P25774 | CTSS | Cathepsin S | inhibitor | targets |
| P27448 | MARK3 | MAP/microtubule affinity-regulating kinase 3 | inhibitor | targets |
| P29317 | EPHA2 | Ephrin type-A receptor 2 | inhibitor | targets |
| P29320 | EPHA3 | Ephrin type-A receptor 3 | inhibitor | targets |
| P29322 | EPHA8 | Ephrin type-A receptor 8 | inhibitor | targets |
| P29323 | EPHB2 | Ephrin type-B receptor 2 | inhibitor | targets |
| P29376 | LTK | Leukocyte tyrosine kinase receptor | inhibitor | targets |
| P29597 | TYK2 | Non-receptor tyrosine-protein kinase TYK2 | inhibitor | targets |
| P30291 | WEE1 | Wee1-like protein kinase | inhibitor | targets |
| P30530 | AXL | Tyrosine-protein kinase receptor UFO | inhibitor | targets |
| P31152 | MAPK4 | Mitogen-activated protein kinase 4 | inhibitor | targets |
| P33981 | TTK | Dual specificity protein kinase TTK | inhibitor | targets |
| P35590 | TIE1 | Tyrosine-protein kinase receptor Tie-1 | inhibitor | targets |
| P35916 | FLT4 | Vascular endothelial growth factor receptor 3 | inhibitor | targets |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | inhibitor | targets |
| P36507 | MAP2K2 | Dual specificity mitogen-activated protein kinase kinase 2 | inhibitor | targets |
| P36888 | FLT3 | Receptor-type tyrosine-protein kinase FLT3 | inhibitor | targets |
| P36896 | ACVR1B | Activin receptor type-1B | inhibitor | targets |
| P36897 | TGFBR1 | TGF-beta receptor type-1 | inhibitor | targets |
| P37173 | TGFBR2 | TGF-beta receptor type-2 | inhibitor | targets |
| P41240 | CSK | Tyrosine-protein kinase CSK | inhibitor | targets |
| P41743 | PRKCI | Protein kinase C iota type | inhibitor | targets |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | inhibitor | targets |
| P42679 | MATK | Megakaryocyte-associated tyrosine-protein kinase | inhibitor | targets |
| P42680 | TEC | Tyrosine-protein kinase Tec | inhibitor | targets |
| P42681 | TXK | Tyrosine-protein kinase TXK | inhibitor | targets |
| P42684 | ABL2 | Tyrosine-protein kinase ABL2 | inhibitor | targets |
| P42685 | FRK | Tyrosine-protein kinase FRK | inhibitor | targets |
| P43403 | ZAP70 | Tyrosine-protein kinase ZAP-70 | inhibitor | targets |
| P43405 | SYK | Tyrosine-protein kinase SYK | inhibitor | targets |
| P45984 | MAPK9 | Mitogen-activated protein kinase 9 | inhibitor | targets |
| P46734 | MAP2K3 | Dual specificity mitogen-activated protein kinase kinase 3 | inhibitor | targets |
| P48729 | CSNK1A1 | Casein kinase I isoform alpha | inhibitor | targets |
| P48736 | PIK3CG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | inhibitor | targets |
| P49759 | CLK1 | Dual specificity protein kinase CLK1 | inhibitor | targets |
| P49760 | CLK2 | Dual specificity protein kinase CLK2 | inhibitor | targets |
| P49761 | CLK3 | Dual specificity protein kinase CLK3 | inhibitor | targets |
| P49840 | GSK3A | Glycogen synthase kinase-3 alpha | inhibitor | targets |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | inhibitor | targets |
| P51451 | BLK | Tyrosine-protein kinase Blk | inhibitor | targets |
| P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | inhibitor | targets |
| P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | inhibitor | targets |
| P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | inhibitor | targets |
| P51955 | NEK2 | Serine/threonine-protein kinase Nek2 | inhibitor | targets |
| P51956 | NEK3 | Serine/threonine-protein kinase Nek3 | inhibitor | targets |
| P51957 | NEK4 | Serine/threonine-protein kinase Nek4 | inhibitor | targets |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | inhibitor | targets |
| P52564 | MAP2K6 | Dual specificity mitogen-activated protein kinase kinase 6 | inhibitor | targets |
| P53350 | PLK1 | Serine/threonine-protein kinase PLK1 | inhibitor | targets |
| P53355 | DAPK1 | Death-associated protein kinase 1 | inhibitor | targets |
| P53667 | LIMK1 | LIM domain kinase 1 | inhibitor | targets |
| P53671 | LIMK2 | LIM domain kinase 2 | inhibitor | targets |
| P53779 | MAPK10 | Mitogen-activated protein kinase 10 | inhibitor | targets |
| P54756 | EPHA5 | Ephrin type-A receptor 5 | inhibitor | targets |
| P54760 | EPHB4 | Ephrin type-B receptor 4 | inhibitor | targets |
| P54762 | EPHB1 | Ephrin type-B receptor 1 | inhibitor | targets |
| P54764 | EPHA4 | Ephrin type-A receptor 4 | inhibitor | targets |
| P57059 | SIK1 | Serine/threonine-protein kinase SIK1 | inhibitor | targets |
| P57078 | RIPK4 | Receptor-interacting serine/threonine-protein kinase 4 | inhibitor | targets |
| P62344 | CDPK1 | Calcium-dependent protein kinase 1 | inhibitor | targets |
| P68400 | CSNK2A1 | Casein kinase II subunit alpha | inhibitor | targets |
| P78356 | PIP4K2B | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | inhibitor | targets |
| P80192 | MAP3K9 | Mitogen-activated protein kinase kinase kinase 9 | inhibitor | targets |
| P9WI81 | pknB | Serine/threonine-protein kinase PknB | inhibitor | targets |
| Q00532 | CDKL1 | Cyclin-dependent kinase-like 1 | inhibitor | targets |
| Q00536 | CDK16 | Cyclin-dependent kinase 16 | inhibitor | targets |
| Q00537 | CDK17 | Cyclin-dependent kinase 17 | inhibitor | targets |
| Q02156 | PRKCE | Protein kinase C epsilon type | inhibitor | targets |
| Q02763 | TEK | Angiopoietin-1 receptor | inhibitor | targets |
| Q02779 | MAP3K10 | Mitogen-activated protein kinase kinase kinase 10 | inhibitor | targets |
| Q04759 | PRKCQ | Protein kinase C theta type | inhibitor | targets |
| Q04771 | ACVR1 | Activin receptor type-1 | inhibitor | targets |
| Q04912 | MST1R | Macrophage-stimulating protein receptor | inhibitor | targets |
| Q05397 | PTK2 | Focal adhesion kinase 1 | inhibitor | targets |
| Q05655 | PRKCD | Protein kinase C delta type | inhibitor | targets |
| Q05940 | SLC18A2 | Synaptic vesicular amine transporter | inhibitor | targets |
| Q06187 | BTK | Tyrosine-protein kinase BTK | inhibitor | targets |
| Q06418 | TYRO3 | Tyrosine-protein kinase receptor TYRO3 | inhibitor | targets |
| Q07912 | TNK2 | Activated CDC42 kinase 1 | inhibitor | targets |
| Q08345 | DDR1 | Epithelial discoidin domain-containing receptor 1 | inhibitor | targets |
| Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | inhibitor | targets |
| Q12851 | MAP4K2 | Mitogen-activated protein kinase kinase kinase kinase 2 | inhibitor | targets |
| Q12852 | MAP3K12 | Mitogen-activated protein kinase kinase kinase 12 | inhibitor | targets |
| Q12866 | MERTK | Tyrosine-protein kinase Mer | inhibitor | targets |
| Q13131 | PRKAA1 | 5'-AMP-activated protein kinase catalytic subunit alpha-1 | inhibitor | targets |
| Q13153 | PAK1 | Serine/threonine-protein kinase PAK 1 | inhibitor | targets |
| Q13163 | MAP2K5 | Dual specificity mitogen-activated protein kinase kinase 5 | inhibitor | targets |
| Q13164 | MAPK7 | Mitogen-activated protein kinase 7 | inhibitor | targets |
| Q13177 | PAK2 | Serine/threonine-protein kinase PAK 2 | inhibitor | targets |
| Q13188 | STK3 | Serine/threonine-protein kinase 3 | inhibitor | targets |
| Q13233 | MAP3K1 | Mitogen-activated protein kinase kinase kinase 1 | inhibitor | targets |
| Q13237 | PRKG2 | cGMP-dependent protein kinase 2 | inhibitor | targets |
| Q13470 | TNK1 | Non-receptor tyrosine-protein kinase TNK1 | inhibitor | targets |
| Q13523 | PRP4K | Serine/threonine-protein kinase PRP4 homolog | inhibitor | targets |
| Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | inhibitor | targets |
| Q13554 | CAMK2B | Calcium/calmodulin-dependent protein kinase type II subunit beta | inhibitor | targets |
| Q13555 | CAMK2G | Calcium/calmodulin-dependent protein kinase type II subunit gamma | inhibitor | targets |
| Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | inhibitor | targets |
| Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | inhibitor | targets |
| Q13873 | BMPR2 | Bone morphogenetic protein receptor type-2 | inhibitor | targets |
| Q13882 | PTK6 | Protein-tyrosine kinase 6 | inhibitor | targets |
| Q14012 | CAMK1 | Calcium/calmodulin-dependent protein kinase type 1 | inhibitor | targets |
| Q14164 | IKBKE | Inhibitor of nuclear factor kappa-B kinase subunit epsilon | inhibitor | targets |
| Q14289 | PTK2B | Protein-tyrosine kinase 2-beta | inhibitor | targets |
| Q14680 | MELK | Maternal embryonic leucine zipper kinase | inhibitor | targets |
| Q15139 | PRKD1 | Serine/threonine-protein kinase D1 | inhibitor | targets |
| Q15208 | STK38 | Serine/threonine-protein kinase 38 | inhibitor | targets |
| Q15303 | ERBB4 | Receptor tyrosine-protein kinase erbB-4 | inhibitor | targets |
| Q15375 | EPHA7 | Ephrin type-A receptor 7 | inhibitor | targets |
| Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | inhibitor | targets |
| Q15569 | TESK1 | Dual specificity testis-specific protein kinase 1 | inhibitor | targets |
| Q15746 | MYLK | Myosin light chain kinase, smooth muscle | inhibitor | targets |
| Q16288 | NTRK3 | NT-3 growth factor receptor | inhibitor | targets |
| Q16512 | PKN1 | Serine/threonine-protein kinase N1 | inhibitor | targets |
| Q16513 | PKN2 | Serine/threonine-protein kinase N2 | inhibitor | targets |
| Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | inhibitor | targets |
| Q16584 | MAP3K11 | Mitogen-activated protein kinase kinase kinase 11 | inhibitor | targets |
| Q16620 | NTRK2 | BDNF/NT-3 growth factors receptor | inhibitor | targets |
| Q16816 | PHKG1 | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | inhibitor | targets |
| Q16832 | DDR2 | Discoidin domain-containing receptor 2 | inhibitor | targets |
| Q2M2I8 | AAK1 | AP2-associated protein kinase 1 | inhibitor | targets |
| Q32MK0 | MYLK3 | Myosin light chain kinase 3 | inhibitor | targets |
| Q52WX2 | SBK1 | Serine/threonine-protein kinase SBK1 | inhibitor | targets |
| Q56UN5 | MAP3K19 | Mitogen-activated protein kinase kinase kinase 19 | inhibitor | targets |
| Q59H18 | TNNI3K | Serine/threonine-protein kinase TNNI3K | inhibitor | targets |
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | inhibitor | targets |
| Q6DT37 | CDC42BPG | Serine/threonine-protein kinase MRCK gamma | inhibitor | targets |
| Q6P3R8 | NEK5 | Serine/threonine-protein kinase Nek5 | inhibitor | targets |
| Q6PHR2 | ULK3 | Serine/threonine-protein kinase ULK3 | inhibitor | targets |
| Q6ZN16 | MAP3K15 | Mitogen-activated protein kinase kinase kinase 15 | inhibitor | targets |
| Q7KZI7 | MARK2 | Serine/threonine-protein kinase MARK2 | inhibitor | targets |
| Q7L7X3 | TAOK1 | Serine/threonine-protein kinase TAO1 | inhibitor | targets |
| Q7Z460 | Q7Z460 | CLIP-associating protein 1 | inhibitor | targets |
| Q86UE8 | TLK2 | Serine/threonine-protein kinase tousled-like 2 | inhibitor | targets |
| Q86V86 | PIM3 | Serine/threonine-protein kinase pim-3 | inhibitor | targets |
| Q86YV6 | MYLK4 | Myosin light chain kinase family member 4 | inhibitor | targets |
| Q8IU85 | CAMK1D | Calcium/calmodulin-dependent protein kinase type 1D | inhibitor | targets |
| Q8IVH8 | MAP4K3 | Mitogen-activated protein kinase kinase kinase kinase 3 | inhibitor | targets |
| Q8IW41 | MAPKAPK5 | MAP kinase-activated protein kinase 5 | inhibitor | targets |
| Q8IY84 | NIM1K | Serine/threonine-protein kinase NIM1 | inhibitor | targets |
| Q8IYT8 | ULK2 | Serine/threonine-protein kinase ULK2 | inhibitor | targets |
| Q8N4C8 | MINK1 | Misshapen-like kinase 1 | inhibitor | targets |
| Q8N568 | DCLK2 | Serine/threonine-protein kinase DCLK2 | inhibitor | targets |
| Q8N5S9 | CAMKK1 | Calcium/calmodulin-dependent protein kinase kinase 1 | inhibitor | targets |
| Q8NEV4 | MYO3A | Myosin-IIIa | inhibitor | targets |
| Q8NFD2 | ANKK1 | Ankyrin repeat and protein kinase domain-containing protein 1 | inhibitor | targets |
| Q8NG66 | NEK11 | Serine/threonine-protein kinase Nek11 | inhibitor | targets |
| Q8NI60 | COQ8A | Atypical kinase COQ8A, mitochondrial | inhibitor | targets |
| Q8TBX8 | PIP4K2C | Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | inhibitor | targets |
| Q8TD08 | MAPK15 | Mitogen-activated protein kinase 15 | inhibitor | targets |
| Q8TD19 | NEK9 | Serine/threonine-protein kinase Nek9 | inhibitor | targets |
| Q8TDR2 | STK35 | Serine/threonine-protein kinase 35 | inhibitor | targets |
| Q8WU08 | STK32A | Serine/threonine-protein kinase 32A | inhibitor | targets |
| Q92772 | CDKL2 | Cyclin-dependent kinase-like 2 | inhibitor | targets |
| Q92918 | MAP4K1 | Mitogen-activated protein kinase kinase kinase kinase 1 | inhibitor | targets |
| Q96BR1 | SGK3 | Serine/threonine-protein kinase Sgk3 | inhibitor | targets |
| Q96D53 | COQ8B | Atypical kinase COQ8B, mitochondrial | inhibitor | targets |
| Q96GD4 | AURKB | Aurora kinase B | inhibitor | targets |
| Q96L34 | MARK4 | MAP/microtubule affinity-regulating kinase 4 | inhibitor | targets |
| Q96NX5 | CAMK1G | Calcium/calmodulin-dependent protein kinase type 1G | inhibitor | targets |
| Q96PY6 | NEK1 | Serine/threonine-protein kinase Nek1 | inhibitor | targets |
| Q96Q40 | CDK15 | Cyclin-dependent kinase 15 | inhibitor | targets |
| Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | inhibitor | targets |
| Q99640 | PKMYT1 | Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | inhibitor | targets |
| Q99759 | MAP3K3 | Mitogen-activated protein kinase kinase kinase 3 | inhibitor | targets |
| Q99808 | SLC29A1 | Equilibrative nucleoside transporter 1 | inhibitor | targets |
| Q9BQI3 | EIF2AK1 | Eukaryotic translation initiation factor 2-alpha kinase 1 | inhibitor | targets |
| Q9BRS2 | RIOK1 | Serine/threonine-protein kinase RIO1 | inhibitor | targets |
| Q9BUB5 | MKNK1 | MAP kinase-interacting serine/threonine-protein kinase 1 | inhibitor | targets |
| Q9BVS4 | RIOK2 | Serine/threonine-protein kinase RIO2 | inhibitor | targets |
| Q9BXA7 | TSSK1B | Testis-specific serine/threonine-protein kinase 1 | inhibitor | targets |
| Q9BYT3 | STK33 | Serine/threonine-protein kinase 33 | inhibitor | targets |
| Q9C098 | DCLK3 | Serine/threonine-protein kinase DCLK3 | inhibitor | targets |
| Q9H093 | NUAK2 | NUAK family SNF1-like kinase 2 | inhibitor | targets |
| Q9H0K1 | SIK2 | Serine/threonine-protein kinase SIK2 | inhibitor | targets |
| Q9H1R3 | MYLK2 | Myosin light chain kinase 2, skeletal/cardiac muscle | inhibitor | targets |
| Q9H2G2 | SLK | STE20-like serine/threonine-protein kinase | inhibitor | targets |
| Q9H2K8 | TAOK3 | Serine/threonine-protein kinase TAO3 | inhibitor | targets |
| Q9H2X6 | HIPK2 | Homeodomain-interacting protein kinase 2 | inhibitor | targets |
| Q9H3Y6 | SRMS | Tyrosine-protein kinase Srms | inhibitor | targets |
| Q9H422 | HIPK3 | Homeodomain-interacting protein kinase 3 | inhibitor | targets |
| Q9H4B4 | PLK3 | Serine/threonine-protein kinase PLK3 | inhibitor | targets |
| Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | inhibitor | targets |
| Q9HBH9 | MKNK2 | MAP kinase-interacting serine/threonine-protein kinase 2 | inhibitor | targets |
| Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | inhibitor | targets |
| Q9NRH2 | SNRK | SNF-related serine/threonine-protein kinase | inhibitor | targets |
| Q9NRP7 | STK36 | Serine/threonine-protein kinase 36 | inhibitor | targets |
| Q9NSY1 | BMP2K | BMP-2-inducible protein kinase | inhibitor | targets |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | inhibitor | targets |
| Q9NYL2 | MAP3K20 | Mitogen-activated protein kinase kinase kinase 20 | inhibitor | targets |
| Q9NYY3 | PLK2 | Serine/threonine-protein kinase PLK2 | inhibitor | targets |
| Q9P0L2 | MARK1 | Serine/threonine-protein kinase MARK1 | inhibitor | targets |
| Q9P286 | PAK5 | Serine/threonine-protein kinase PAK 5 | inhibitor | targets |
| Q9P289 | STK26 | Serine/threonine-protein kinase 26 | inhibitor | targets |
| Q9P2K8 | EIF2AK4 | eIF-2-alpha kinase GCN2 | inhibitor | targets |
| Q9UBF8 | PI4KB | Phosphatidylinositol 4-kinase beta | inhibitor | targets |
| Q9UEE5 | STK17A | Serine/threonine-protein kinase 17A | inhibitor | targets |
| Q9UEW8 | STK39 | STE20/SPS1-related proline-alanine-rich protein kinase | inhibitor | targets |
| Q9UF33 | EPHA6 | Ephrin type-A receptor 6 | inhibitor | targets |
| Q9UHD2 | TBK1 | Serine/threonine-protein kinase TBK1 | inhibitor | targets |
| Q9UIK4 | DAPK2 | Death-associated protein kinase 2 | inhibitor | targets |
| Q9UK32 | RPS6KA6 | Ribosomal protein S6 kinase alpha-6 | inhibitor | targets |
| Q9UKE5 | TNIK | TRAF2 and NCK-interacting protein kinase | inhibitor | targets |
| Q9UKI8 | TLK1 | Serine/threonine-protein kinase tousled-like 1 | inhibitor | targets |
| Q9UL54 | TAOK2 | Serine/threonine-protein kinase TAO2 | inhibitor | targets |
| Q9UM73 | ALK | ALK tyrosine kinase receptor | inhibitor | targets |
| Q9UPZ9 | CILK1 | Serine/threonine-protein kinase ICK | inhibitor | targets |
| Q9UQB9 | AURKC | Aurora kinase C | inhibitor | targets |
| Q9UQM7 | CAMK2A | Calcium/calmodulin-dependent protein kinase type II subunit alpha | inhibitor | targets |
| Q9Y2H1 | STK38L | Serine/threonine-protein kinase 38-like | inhibitor | targets |
| Q9Y2H9 | MAST1 | Microtubule-associated serine/threonine-protein kinase 1 | inhibitor | targets |
| Q9Y2K2 | SIK3 | Serine/threonine-protein kinase SIK3 | inhibitor | targets |
| Q9Y2U5 | MAP3K2 | Mitogen-activated protein kinase kinase kinase 2 | inhibitor | targets |
| Q9Y463 | DYRK1B | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | inhibitor | targets |
| Q9Y4K4 | MAP4K5 | Mitogen-activated protein kinase kinase kinase kinase 5 | inhibitor | targets |
| Q9Y616 | IRAK3 | Interleukin-1 receptor-associated kinase 3 | inhibitor | targets |
| Q9Y6E0 | STK24 | Serine/threonine-protein kinase 24 | inhibitor | targets |
| Q9Y6R4 | MAP3K4 | Mitogen-activated protein kinase kinase kinase 4 | inhibitor | targets |
| Q9UNQ0 | ABCG2 | Broad substrate specificity ATP-binding cassette transporter ABCG2 | inhibitor | transporters |
| Q2M3G0 | Q2M3G0 | ATP-binding cassette sub-family B member 5 | substrate | transporters |